Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
David Yi
ID:
1b839951-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
30 articles
Federal Court Notice on Use of Artificial Intelligence in Court Proceedings
Pharma in Brief ·
January 9, 2024
cite
The Ontario Superior Court dismisses a generic manufacturer’s claim for damages under section 8 of the <em>PM(NOC) Regulations</em>
Pharma in Brief ·
May 4, 2023
cite
Supreme Court denies leave to appeal in generic Statute of Monopolies case
Pharma in Brief ·
May 4, 2023
cite
ONCA Confirms Generics Limited to Section 8 Damages in the Face of an Innovator’s Legitimate Exercise of Rights under the PM(NOC) Regulations
Pharma in Brief ·
August 25, 2022
cite
Amendments to the Federal Courts Rules
Pharma in Brief ·
January 12, 2022
cite
Previous
1
2
...
6
Next
Practice Areas
Health Care and Life Sciences
Jurisdictions
Canada
North America
